During a live event, Hannah Choe, MD, analyzed key findings from the AGAVE-201 trial of axatilimab in chronic graft-vs-host disease. A significant number of patients who develop chronic graft-vs-host ...
Special Report: Entropy Neurodynamics has completed dosing of its IV-infused psilocin TRP-8803 for the first patient ...
Zacks Investment Research on MSN
BAX highlights EMR-integrated smart pumps boost patient safety & care
Baxter International Inc. BAX recently shared real-world data at the American Society of Health-System Pharmacists (“ASHP”) ...
The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
SheBuysTravel on MSN
I spent four nights at a Miami menopause retreat. Here's what I loved, and what I'm still not sure about
I’m a wife, mom and a globetrotting travel writer. I’m also riding the hormonal rollercoaster of perimenopause. Many of the 1 ...
Lunsumio VELO reduces administration time from 2-4 hours to approximately one minute –– Availability of Lunsumio VELO allows ...
Every day, children are facing long treatments at Albany Medical Center’s infusion and apheresis centers, where they are sometimes spending hours in a hospital bed, hooked up to IV medications.One of ...
With all the buzzwords surrounding artificial intelligence, from smiling promotions to angry chagrins—promises that it will ...
This article is based on TheStreet’s Stock & Markets Podcast. Hosted by Chris Versace, the veteran Wall Street investor and ...
Treatment with Kisunla was associated with sustained clinical benefits, specifically less symptom worsening and significant ...
The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback